Spiramycin is used in veterinary medicine for the treatment of bacteri
al and mycoplasmal infections. With regard-to toxicological safety a m
aximum residue limit (MRL) of 200 mu g/kg for the sum of spiramycin an
d neospiramycin (metabolite) in milk is fixed (EU-Regulation 1442/95).
Up to now there is no screening test available for the simultaneous i
dentification and quantification of spiramycin at the MRL. An enzyme i
mmunoassay for the determination of spiramycin in raw milk is presente
d. Hens were immunized using a spiramycin-BSA-conjugate produced in a
two step coupling method. Specific antibodies (IgY) could be extracted
from egg yolk by precipitation with polyethylene glycol. The ELISA wa
s carried out as an indirect competitive antibody-capture test with a
detection limit of 5.6 mu g/kg. Repeatability (r) of the ELISA was tes
ted by analyzing standard solutions of spiramycin in raw milk (n = 6 f
or each concentration). Coefficients of variation were between 5.1 and
7.9 %. Results after examination of spiked blind samples demonstrated
that classification of positives and negatives as well as quantificat
ion up to 150 mu g/kg is possible. For quantitative detection of spira
mycin at the final MRL sample dilution may be necessary.